Prognostic and predictive factors in patients with advanced penile cancer receiving salvage (2nd or later line) systemic treatment: a retrospective, multi-center study

Prognostic and predictive factors in patients with advanced penile cancer receiving salvage (2nd or later line) systemic treatment: a retrospective, multi-center study

AbstractIntroduction & objectives: Metastatic penile squamous cell carcinoma (PSCC) is associated with dismal outcomes with median overall survival (OS) of 6-12 months in the first-line and <6 months in the salvage setting. Given the rarity of this disease, randomized trials are difficult. Pr...

Full description

Bibliographic Details
Main Authors: Carlo Buonerba, Giuseppe Di Lorenzo, Gregory Pond, Giacomo Cartenì, Sarah Scagliarini, Antonio Rozzi, Fernando J Quevedo, Tanya Dorff, Lucia Nappi, Gaetano Lanzetta, Lance Pagliaro, Bernhard J. Eigl, Gurudatta Naik, Matteo Ferro, Sabino De Placido, Guru Sonpavde
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Pharmacology
Subjects:
Penile Neoplasms
chemotherapy
Squamous cell carcinoma
cetuximab
Prognostic biomarkers
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00487/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00487/full

Similar Items